Abstract
Amphidinolide E is a 19-membered macrolide possessing potent cytoxic activity. The macrolide core having two key intermediates alcohol and acid was synthesized efficiently. The THF ring segment was synthesized from Dglucose as chiral precursor, whereas the cis-tetrahydrofuran ring was established by stereoselective intramolecular oxymercuration reaction. The acid component having E-diene was established by Stille cross coupling of vinyl iodo and vinly stannane segment. Coupling reaction of acid segment and alcohol was examined.
Keywords: Amphidinolide, Bestmann reagent, natural product, oxymercuration, stereoselectivity, stille coupling, Takai olefination, biological, intermediates, Debenzylation
Letters in Organic Chemistry
Title:Synthesis of Key Fragments of 19-Membered Cytotoxic Macrolide Amphidinolide E
Volume: 10 Issue: 1
Author(s): Seetaram Mohapatra, Sabita Nayak, Sambita K. Mishra and Priyabrata Pattanaik
Affiliation:
Keywords: Amphidinolide, Bestmann reagent, natural product, oxymercuration, stereoselectivity, stille coupling, Takai olefination, biological, intermediates, Debenzylation
Abstract: Amphidinolide E is a 19-membered macrolide possessing potent cytoxic activity. The macrolide core having two key intermediates alcohol and acid was synthesized efficiently. The THF ring segment was synthesized from Dglucose as chiral precursor, whereas the cis-tetrahydrofuran ring was established by stereoselective intramolecular oxymercuration reaction. The acid component having E-diene was established by Stille cross coupling of vinyl iodo and vinly stannane segment. Coupling reaction of acid segment and alcohol was examined.
Export Options
About this article
Cite this article as:
Mohapatra Seetaram, Nayak Sabita, K. Mishra Sambita and Pattanaik Priyabrata, Synthesis of Key Fragments of 19-Membered Cytotoxic Macrolide Amphidinolide E, Letters in Organic Chemistry 2013; 10 (1) . https://dx.doi.org/10.2174/1570178611310010015
DOI https://dx.doi.org/10.2174/1570178611310010015 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Colon as Target for Drug Delivery
Current Drug Therapy Bevacizumab for Malignant Brain Gliomas. Which is the Current Evidence?
Recent Patents on Inflammation & Allergy Drug Discovery The Neurovascular Unit: Focus on the Regulation of Arterial Smooth Muscle Cells
Current Neurovascular Research Special Issue on Programmed Cell Death in Stroke
Current Neuropharmacology Emerging Immunotargets and Immunotherapies in Prostate Cancer
Current Drug Targets Functional Genome and Proteome Analyses of Cutaneous Autoimmune Diseases
Current Pharmaceutical Design Silent Partner in Blood Vessel Homeostasis? Pervasive Role of Nitric Oxide in Vascular Disease
Current Hypertension Reviews The ERK 1 and 2 Pathway in the Nervous System: From Basic Aspects to Possible Clinical Applications in Pain and Visceral Dysfunction
Current Neuropharmacology Ruthenium as an Effective Nitric Oxide Scavenger
Current Topics in Medicinal Chemistry Molecular Chaperone Activity and Biological Regulatory Actions of the TPR-Domain Immunophilins FKBP51 and FKBP52
Current Protein & Peptide Science Spondyloarthritis in Asian Countries – An Overview
Current Rheumatology Reviews Recent Advances in Gastric Floating Drug Delivery Technology: A Review
Current Drug Delivery Patent Perspectives for Corticosteroids Based Ophthalmic Therapeutics
Recent Patents on Drug Delivery & Formulation Tackling Chronic Pain and Inflammation through the Purinergic System
Current Medicinal Chemistry Juvenile Systemic Lupus Erythematosus
Current Pediatric Reviews Editorial [Hot Topic: Modulation and New Mediators in Inflammation Executive (Guest Editor: Frank A. Redegeld)]
Current Pharmaceutical Design Death Due to COVID-19 in an Infant with Combined Immunodeficiencies
Endocrine, Metabolic & Immune Disorders - Drug Targets Novel Therapeutic Approaches to Regulate Human Dihydrofolate Reductase Activity and Expression
Current Enzyme Inhibition Obstetric Anaesthesia and Obesity
Current Women`s Health Reviews Aminooxy-Acetic Acid Inhibits Experimental Autoimmune Uveitis by Modulating the Balance between Effector and Regulatory Lymphocyte Subsets
Current Molecular Medicine